Glyco- and peptidomimetics from three-component joullié-ugi coupling show selective antiviral activity

Journal of the American Chemical Society

Volumn 127, Issue 2, 2005, Pages 506-507

  Chapman, Timothy M ^a,d   Davies, Ieuan G ^a   Gu, Baohua ^b   Block, Timothy M ^b   Scopes, David I C ^c   Hay, Philip A ^c,e   Courtney, Stephen M ^c,e   McNeill, Luke A ^a   Schofield, Christopher J ^a   Davis, Benjamin G ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^c The Forum   (United Kingdom)

^d Chemistry Dept   (Canada)

^e EVOTEC UK LTD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOHYDRATE; CERAMIDE GLUCOSYLTRANSFERASE; DIHYDROXYPROLYL; ERYTHRITOL; GLYCOSIDASE; GLYCOSYLTRANSFERASE; IMINE; PEPTIDE; PROLINE DERIVATIVE; THREITOL; UNCLASSIFIED DRUG;

ANTIVIRAL ACTIVITY; ARTICLE; CHLORINATION; CHROMATOGRAPHY; DEPROTECTION REACTION; HYDROPHOBICITY; PROTEIN PROCESSING; STEREOISOMERISM;

ANTIVIRAL AGENTS; AZA COMPOUNDS; BIOMIMETIC MATERIALS; CARBOHYDRATES; DIARRHEA VIRUSES, BOVINE VIRAL; ENZYME INHIBITORS; ERYTHRITOL; GLYCOPEPTIDES; GLYCOSIDE HYDROLASES; HEPATITIS B VIRUS; HYDROXYPROLINE; PYRROLIDINES; SUGAR ALCOHOLS;

EID: 12944279761     PISSN: 00027863     EISSN: None     Source Type: Journal    
DOI: 10.1021/ja043924l     Document Type: Article

References (54)

1. (a) Winchester, B.; Fleet, G. W. J. Glycobiology 1992, 2, 199.
2. (b) Winchester, B.; al Daher, S.; Carpenter, N. C.; Cenci di Bello, I.; Choi, S. S.; Fairbanks, A. J.; Fleet, G. W. J. Biochem. J. 1993, 290, 743.
3. (a) Lázaro, A.; Garcia, L.; Correia, C. R. D. Tetrahedron Lett. 2003, 44, 1553.
4. (b) Chakraborty, T. K.; Srinivasu, P.; Kumar, S. K.; Kunwar, A. C. J. Org. Chem. 2002, 67, 2093.
5. (a) Chapman, T. M.; Courtney, S.; Hay, P.; Davis, B. G. Chem. Eur. J. 2003, 9, 3397.
6. (b) Davis, B. G.; Maughan, M. A. T.; Chapman, T. M.; Villard, R.; Courtney, S. Org. Lett. 2002, 4, 103.
7. (a) Ugi, I.; Steinbrückner, C. Chem. Ber. 1961, 94, 734.
8. (b) Ugi, I. Angew. Chem., Int. Ed. Engl. 1962, 1, 8.
9. (a) Sutherlin, D. P.; Stark, T. M.; Hughes, R.; Armstrong, R. W. J. Org. Chem. 1996, 61, 8350.
10. (b) Isenring, H. P.; Hofheinz, W. Synthesis 1981, 385.
11. (c) Hoel, A. M. L.; Nielsen, J. Tetrahedron Lett. 1999, 40, 3941.
12. (d) Liu, L.; Li, C. P.; Cochran, S.; Ferro, V. Bioorg. Med. Chem. Lett. 2004, 14, 2221.
13. (e) Geday, S.; Van der Eycken, J.; Fulöp, F. Org. Lett. 2002, 4, 1967.
14. Bowers, M. M.; Carroll, P.; Joullié, M. M. J. Chem. Soc., Perkin Trans. 1 1989, 857.
15. More recently, tetrahydropyridines have been used vs aldehyde/amine condensate. See: Maison, W.; Lützen, A.; Kosten, M.; Schlemminger, I.; Westerhoff, O.; Martens, J. J. Chem. Soc.,; Perkin Trans. 1 1999, 3515.
16. (a) Furneaux, R. H.; Limberg, G.; Tyler, P. C.; Schramm, V. L. Tetrahedron 1997, 53, 2915.
17. (b) Evans, G. B.; Furneaux, R. H.; Hutchison, T. L.; Kesar, H. S.; Morris, P. E.; Schramm, V. L.; Tyler, P. C. J. Org. Chem. 2001, 66, 5723.
18. (c) Lohse, A.; Jensen, K. B.; Lundgren, K.; Bols, M. Bioorg. Med. Chem. 1999, 7, 1965.
19. (d) Wright, P. A.; Wilmouth, R. C.; Clifton, I. J.; Schofield, C. J. Eur. J. Biochem. 2001, 268, 2969.
20. (a) Taylor, C. M.; Weir, C. A. J. Org. Chem. 2000, 65, 1414.
21. (b) Jenkins, C. L.; Bretscher, L. E.; Guzei, I. A.; Raines, R. T. J. Am. Chem. Soc. 2003, 125, 6422.
22. (c) Kalaus, G.; Malkieh, N.; Kajtár-Peredy, M.; Brlik, J.; Szabó, L.: Szántay, C. J. Org. Chem. 1988, 53, 42.
23. (a) Steger, M.; Hubschwerlen, C.; Schmid, G. Bioorg. Med. Chem. Lett. 2001, 11, 2537.
24. (b) Taylor, C. M.; Barker, W. D.; Weir, C. A.; Park, J. H. J. Org. Chem. 2002, 67, 4466.
25. (c) Weir, C. A.; Taylor, C. M. J. Org. Chem. 1999, 64, 1554.
26. (d) Fujii, M.; Miura, T.; Kajimoto, T.; Ida, Y. Synlett 2000, 1046.
27. Typically no higher than ∼70% and up to 10 days. See ref 9.
28. Albeit modest in comparison to other compound libraries, this is a promising step for azasugars. For leading examples, see: (a) Saotome, C.; Wong, C.-H.; Kanie, O. Chem. Biol. 2001, 8, 1061 (27 member). (b) Wu, C.-Y.; Chang, C.-F.; Chen, J. S.-Y.; Wong, C.-H.; Lin, C.-H. Angew. Chem., Int. Ed. 2003, 42, 4661 (60 members). (c) Gerber-Lemaire, S.; Popowycz, F.; Rodríguez- García, E.; Asenjo, A. T. C.; Robina, I.; Vogel, P. ChemBioChem. 2002, 5, 466 (96 member).
29. Albeit modest in comparison to other compound libraries, this is a promising step for azasugars. For leading examples, see: (a) Saotome, C.; Wong, C.-H.; Kanie, O. Chem. Biol. 2001, 8, 1061 (27 member). (b) Wu, C.-Y.; Chang, C.-F.; Chen, J. S.-Y.; Wong, C.-H.; Lin, C.-H. Angew. Chem., Int. Ed. 2003, 42, 4661 (60 members). (c) Gerber-Lemaire, S.; Popowycz, F.; Rodríguez- García, E.; Asenjo, A. T. C.; Robina, I.; Vogel, P. ChemBioChem. 2002, 5, 466 (96 member).
30. Albeit modest in comparison to other compound libraries, this is a promising step for azasugars. For leading examples, see: (a) Saotome, C.; Wong, C.-H.; Kanie, O. Chem. Biol. 2001, 8, 1061 (27 member). (b) Wu, C.-Y.; Chang, C.-F.; Chen, J. S.-Y.; Wong, C.-H.; Lin, C.-H. Angew. Chem., Int. Ed. 2003, 42, 4661 (60 members). (c) Gerber-Lemaire, S.; Popowycz, F.; Rodríguez- García, E.; Asenjo, A. T. C.; Robina, I.; Vogel, P. ChemBioChem. 2002, 5, 466 (96 member).
31. Interestingly, little selectivity (dr 1:1) was seen for threitol 7vD.
32. (a) Butters, T. D.; van den Broek, L. A. G. M.; Fleet, G. W. J.; Krulle T. M.; Wormald, M. R.; Dwek, R. A.; Platt, F. M. Tetrahedron: Asymmetry 2000, 11, 113.
33. (b) Fernandez, J. H.; Hayashi, M. A. F.; Camrgo, A. C. M.; Neshich, G. Biochem. Biophys. Res. Commun. 2003, 308, 219.
34. See Supporting Information for further details.
35. The reaction with benzyl isocyanide gave an anomalous yield of 49%.
36. N-Methylpyrrole-2-carboxylic acid gave no Ugi product.
37. No efficiency difference for either of the two enantiomers of imine 3.
38. Lockhoff, O. Angew. Chem., Int. Ed. 1998, 37, 3436.
39. Godage, H. Y.; Fairbanks, A. J. Tetrahedron Lett. 2000, 41, 7589.
40. Sawkar, A. R.; Cheng, W.-C.; Beutler, E.; Wong, C.-H.; Balch, W. E.; Kelly, J. W. Proc. Natl Acad. Sci. U.S.A. 2002, 99, 15428.
41. This was unexpected since imino sugars with hydrophobic substituents are inhibitors of GCS (see: Platt, F. M.; Neises, G. R.; Karlsson, G. B.; Dwek, R. A.; Butters, T. D. J. Biol. Chem. 1994, 269, 27108) and glycosidases (refs 3 and 8).
42. Reduction with L-selectride or 9-BBN both proceeded sluggishly, even at reflux, and no trace of the reduction product could be detected.
43. Soai, K.; Ookawa, A. J. Org. Chem. 1986, 51, 4000.
44. Although selectivities for 10 vs 11 were poor, pleasingly and strikingly, no reduction of the secondary amide was detected.
45. Hewitson, K.; McNeill, L.; Schofield, C. J. Curr. Pharm. Des. 2004, 10, 821.
46. Factor inhibiting hypoxia-inducible factor, which catalyzes hydroxylation of VNAP motifs. See: (a) Hewitson, K. S.; McNeill, L. A.; Riordan, M. V.; Tian, Y. M.; Bullock, A. N.; Welford, R. W.; Elkins, J. M.; Oldham, N. J.; Battacharya, S.; Gleadle, J. M.; Ratcliffe, P. J.; Pugh, C. W.; Schofield, C. J. J. Biol. Chem. 2002, 277, 26351. (b) Lando, D.; Peel, D. J.; Whelan, D.; Gorman, J.; Whitelaw, M. Science 2002, 295, 858.
47. Factor inhibiting hypoxia-inducible factor, which catalyzes hydroxylation of VNAP motifs. See: (a) Hewitson, K. S.; McNeill, L. A.; Riordan, M. V.; Tian, Y. M.; Bullock, A. N.; Welford, R. W.; Elkins, J. M.; Oldham, N. J.; Battacharya, S.; Gleadle, J. M.; Ratcliffe, P. J.; Pugh, C. W.; Schofield, C. J. J. Biol. Chem. 2002, 277, 26351. (b) Lando, D.; Peel, D. J.; Whelan, D.; Gorman, J.; Whitelaw, M. Science 2002, 295, 858.
48. Isoform of the prolyl hydroxylase domain containing hydroxylases. See: (a) Jaakkola, P.; Mole, D. R.; Tian, Y.-M.; Wilson, M. I.; Gielbert, J.; Gaskell, S. J.; von Kriegsheim, A.; Hebestreit, H. F.; Mukherji, M.; Schofield, C. J.; Maxwell, P. H.; Pugh, C. W.; Ratcliffe, P. J. Science 2001, 292, 468. (b) Ivan, M.; Kondo, K.; Yang, H.; Kim, W.; Valiando, J.; Ohh, M.; Salic, A.; Asara, J. M.; Lane, W. S.; Kaelin, W. G., Jr. Science 2001, 292, 464. (c) Epstein, A. C. R.; Gleadle, J. M.; McNeill, L. A.; Hewitson, K. S.; O'Rourke, J.; Mole, D. R.; Mukherji, M.; Metzen, E.; Wilson, M. I.; Dhanda, A.; Tian, Y.-M.; Masson, N.; Hamilton, D. L.; Jaakola, P.; Barstead, R.; Hodgkin, J.; Maxwell, P. H.; Pugh, C. W.; Schofield, C. J.; Ratcliffe, P. J. Cell 2001, 107, 43. (d) Schofield, C. J.; Ratcliffe, P. J. Nat. Rev. Mol. Cell. Biol. 2004, 5, 343.
49. Isoform of the prolyl hydroxylase domain containing hydroxylases. See: (a) Jaakkola, P.; Mole, D. R.; Tian, Y.-M.; Wilson, M. I.; Gielbert, J.; Gaskell, S. J.; von Kriegsheim, A.; Hebestreit, H. F.; Mukherji, M.; Schofield, C. J.; Maxwell, P. H.; Pugh, C. W.; Ratcliffe, P. J. Science 2001, 292, 468. (b) Ivan, M.; Kondo, K.; Yang, H.; Kim, W.; Valiando, J.; Ohh, M.; Salic, A.; Asara, J. M.; Lane, W. S.; Kaelin, W. G., Jr. Science 2001, 292, 464. (c) Epstein, A. C. R.; Gleadle, J. M.; McNeill, L. A.; Hewitson, K. S.; O'Rourke, J.; Mole, D. R.; Mukherji, M.; Metzen, E.; Wilson, M. I.; Dhanda, A.; Tian, Y.-M.; Masson, N.; Hamilton, D. L.; Jaakola, P.; Barstead, R.; Hodgkin, J.; Maxwell, P. H.; Pugh, C. W.; Schofield, C. J.; Ratcliffe, P. J. Cell 2001, 107, 43. (d) Schofield, C. J.; Ratcliffe, P. J. Nat. Rev. Mol. Cell. Biol. 2004, 5, 343.
50. Isoform of the prolyl hydroxylase domain containing hydroxylases. See: (a) Jaakkola, P.; Mole, D. R.; Tian, Y.-M.; Wilson, M. I.; Gielbert, J.; Gaskell, S. J.; von Kriegsheim, A.; Hebestreit, H. F.; Mukherji, M.; Schofield, C. J.; Maxwell, P. H.; Pugh, C. W.; Ratcliffe, P. J. Science 2001, 292, 468. (b) Ivan, M.; Kondo, K.; Yang, H.; Kim, W.; Valiando, J.; Ohh, M.; Salic, A.; Asara, J. M.; Lane, W. S.; Kaelin, W. G., Jr. Science 2001, 292, 464. (c) Epstein, A. C. R.; Gleadle, J. M.; McNeill, L. A.; Hewitson, K. S.; O'Rourke, J.; Mole, D. R.; Mukherji, M.; Metzen, E.; Wilson, M. I.; Dhanda, A.; Tian, Y.-M.; Masson, N.; Hamilton, D. L.; Jaakola, P.; Barstead, R.; Hodgkin, J.; Maxwell, P. H.; Pugh, C. W.; Schofield, C. J.; Ratcliffe, P. J. Cell 2001, 107, 43. (d) Schofield, C. J.; Ratcliffe, P. J. Nat. Rev. Mol. Cell. Biol. 2004, 5, 343.
51. Isoform of the prolyl hydroxylase domain containing hydroxylases. See: (a) Jaakkola, P.; Mole, D. R.; Tian, Y.-M.; Wilson, M. I.; Gielbert, J.; Gaskell, S. J.; von Kriegsheim, A.; Hebestreit, H. F.; Mukherji, M.; Schofield, C. J.; Maxwell, P. H.; Pugh, C. W.; Ratcliffe, P. J. Science 2001, 292, 468. (b) Ivan, M.; Kondo, K.; Yang, H.; Kim, W.; Valiando, J.; Ohh, M.; Salic, A.; Asara, J. M.; Lane, W. S.; Kaelin, W. G., Jr. Science 2001, 292, 464. (c) Epstein, A. C. R.; Gleadle, J. M.; McNeill, L. A.; Hewitson, K. S.; O'Rourke, J.; Mole, D. R.; Mukherji, M.; Metzen, E.; Wilson, M. I.; Dhanda, A.; Tian, Y.-M.; Masson, N.; Hamilton, D. L.; Jaakola, P.; Barstead, R.; Hodgkin, J.; Maxwell, P. H.; Pugh, C. W.; Schofield, C. J.; Ratcliffe, P. J. Cell 2001, 107, 43. (d) Schofield, C. J.; Ratcliffe, P. J. Nat. Rev. Mol. Cell. Biol. 2004, 5, 343.
52. Zitzmann, N.; Mehta, A. S.; Carrouée, S.; Butters, T. D.; Platt, F. M.; McCauley, J.; Blumberg, B.; Dwek, R. A.; Block, T. M. Proc. Natl. Acad. Sci. U.S.A. 1999, 96, 11878.
53. A surrogate in the absence of a suitable HCV system since, as Flaviviridae, both share protein homology and replication strategies. It also has severe effects upon infected herds, leading to an estimated economic loss of $20 million per million calvings. See: Houe, H. Biologicals 2003, 31, 137.
54. Durantel, D.; Branza-Nichita, N.; Carrouée-Durantel, S.; Butters, T. D.; Dwek, R. A.; Zitzmann, N. J. Virol. 2001, 75, 8987.